Using treatment process data to predict maintained smoking abstinence
Steffani R Bailey, Sarah A Hammer, Susan W Bryson, Alan F Schatzberg, Joel D Killen, Steffani R Bailey, Sarah A Hammer, Susan W Bryson, Alan F Schatzberg, Joel D Killen
Abstract
Objectives: To identify distinct subgroups of treatment responders and nonresponders to aid in the development of tailored smoking-cessation interventions for long-term maintenance using signal detection analysis (SDA).
Methods: The secondary analyses (n = 301) are based on data obtained in our randomized clinical trial designed to assess the efficacy of extended cognitive behavior therapy for cigarette smoking cessation. Model 1 included only pretreatment factors, demographic characteristics, and treatment assignment. Model 2 included all Model 1 variables, as well as clinical data measured during treatment.
Results: SDA was successfully able to identify smokers with varying probabilities of maintaining abstinence from end-of-treatment to 52-week follow-up; however, the inclusion of clinical data obtained over the course of treatment in Model 2 yielded very different partitioning parameters.
Conclusions: The findings from this study may enable researchers to target underlying factors that may interact to promote maintenance of long-term smoking behavior change.
Figures
![Figure 1. Evaluation of an Optimally Efficient…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4710141/bin/nihms746139f1.jpg)
Figure 2. Evaluation of an Optimally Efficient…
Figure 2. Evaluation of an Optimally Efficient Algorithm to Predict Maintained Smoking Abstinence Using Pretreatment…
- Cost-effectiveness of extended cessation treatment for older smokers.Barnett PG, Wong W, Jeffers A, Munoz R, Humfleet G, Hall S. Barnett PG, et al. Addiction. 2014 Feb;109(2):314-22. doi: 10.1111/add.12404. Epub 2013 Dec 13. Addiction. 2014. PMID: 24329972 Free PMC article. Clinical Trial.
- Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.Hendricks PS, Delucchi KL, Hall SM. Hendricks PS, et al. Drug Alcohol Depend. 2010 Jun 1;109(1-3):114-9. doi: 10.1016/j.drugalcdep.2009.12.021. Epub 2010 Jan 21. Drug Alcohol Depend. 2010. PMID: 20096510 Free PMC article. Clinical Trial.
- Psychological intervention and antidepressant treatment in smoking cessation.Hall SM, Humfleet GL, Reus VI, Muñoz RF, Hartz DT, Maude-Griffin R. Hall SM, et al. Arch Gen Psychiatry. 2002 Oct;59(10):930-6. doi: 10.1001/archpsyc.59.10.930. Arch Gen Psychiatry. 2002. PMID: 12365880 Clinical Trial.
- Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ. Gray KM, et al. JAMA Pediatr. 2019 Dec 1;173(12):1146-1153. doi: 10.1001/jamapediatrics.2019.3553. JAMA Pediatr. 2019. PMID: 31609433 Free PMC article. Clinical Trial.
- Interventions to reduce harm from continued tobacco use.Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Lindson-Hawley N, et al. Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article. Review.
- Research Support, N.I.H., Extramural
- Adolescent
- Adult
- Aged
- Cognitive Behavioral Therapy / methods
- Female
- Humans
- Male
- Middle Aged
- Models, Psychological
- Outcome and Process Assessment, Health Care / methods*
- Randomized Controlled Trials as Topic
- Secondary Prevention
- Signal Detection, Psychological
- Smoking Cessation / methods*
- Tobacco Use Disorder / classification
- Tobacco Use Disorder / prevention & control*
- Tobacco Use Disorder / therapy*
- Full Text Sources
- Medical
![Figure 2. Evaluation of an Optimally Efficient…](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4710141/bin/nihms746139f2.jpg)
Source: PubMed